<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Rajput RV</submitter><pubmed_abstract>Patients with severe aplastic anaemia (SAA) are often not vaccinated against viruses due to concerns of ineffective protective antibody response and potential for pathogenic global immune system activation, leading to relapse. We evaluated the impact of COVID-19 vaccination on haematological indices and disease status and characterized the humoural and cellular responses to vaccination in 50 SAA patients, who were previously treated with immunosuppressive therapy (IST). There was no significant difference in haemoglobin (p = 0.52), platelet count (p = 0.67), absolute lymphocyte (p = 0.42) and neutrophil (p = 0.98) counts prior to and after completion of vaccination series. Relapse after vaccination, defined as a progressive decline in counts requiring treatment, occurred in three patients </pubmed_abstract><journal>British journal of haematology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9538485</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.</pubmed_title><pmcid>PMC9538485</pmcid><pubmed_authors>Novik L</pubmed_authors><pubmed_authors>Gordon I</pubmed_authors><pubmed_authors>Ma X</pubmed_authors><pubmed_authors>Groarke EM</pubmed_authors><pubmed_authors>Boswell KL</pubmed_authors><pubmed_authors>Narpala SR</pubmed_authors><pubmed_authors>Lotter J</pubmed_authors><pubmed_authors>Naisan M</pubmed_authors><pubmed_authors>Koup RA</pubmed_authors><pubmed_authors>Jean-Baptiste N</pubmed_authors><pubmed_authors>Rios OJ</pubmed_authors><pubmed_authors>Prabhakaran M</pubmed_authors><pubmed_authors>Wang JL</pubmed_authors><pubmed_authors>Darden I</pubmed_authors><pubmed_authors>Serebryannyy L</pubmed_authors><pubmed_authors>Willis J</pubmed_authors><pubmed_authors>Rajput RV</pubmed_authors><pubmed_authors>Young NS</pubmed_authors><pubmed_authors>Wu CO</pubmed_authors><pubmed_authors>McDermott A</pubmed_authors><pubmed_authors>Gaudinski M</pubmed_authors><pubmed_authors>Moore C</pubmed_authors><pubmed_authors>Patel BA</pubmed_authors><pubmed_authors>Superata J</pubmed_authors><pubmed_authors>Lin BC</pubmed_authors><pubmed_authors>Trost J</pubmed_authors><pubmed_authors>Carroll R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.</name><description>Patients with severe aplastic anaemia (SAA) are often not vaccinated against viruses due to concerns of ineffective protective antibody response and potential for pathogenic global immune system activation, leading to relapse. We evaluated the impact of COVID-19 vaccination on haematological indices and disease status and characterized the humoural and cellular responses to vaccination in 50 SAA patients, who were previously treated with immunosuppressive therapy (IST). There was no significant difference in haemoglobin (p = 0.52), platelet count (p = 0.67), absolute lymphocyte (p = 0.42) and neutrophil (p = 0.98) counts prior to and after completion of vaccination series. Relapse after vaccination, defined as a progressive decline in counts requiring treatment, occurred in three patients </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-21T16:48:21.962Z</modification><creation>2025-04-05T11:38:38.197Z</creation></dates><accession>S-EPMC9538485</accession><cross_references><pubmed>36128909</pubmed><doi>10.1111/bjh.18456</doi></cross_references></HashMap>